Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.

Thomas W von Geldern; Noah Tu; Philip R Kym; James T Link; Hwan-Soo Jae; Chunqiu Lai; Theresa Apelqvist; Patrik Rhonnstad; Lars Hagberg; Konrad Koehler

doi:10.1021/jm0400045

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.

Identifier:nobleid.org/w1/20260515/EFF1D080

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EFF1D080.svg?ark=w1%2F20260515%2FEFF1D080)](https://nobleid.org/work/w1/20260515/EFF1D080)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.

Identifier:nobleid.org/w1/20260515/EFF1D080

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/EFF1D080.svg?ark=w1%2F20260515%2FEFF1D080)](https://nobleid.org/work/w1/20260515/EFF1D080)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work